Encouraging HIV 'Cure' Data Strengthen Abivax

Hepatitis C is effectively cured. Could this success be replicated in another serious chronic viral condition ‒ HIV? Abivax, which last year abandoned its hepatitis B lead program, has bounced back with data suggesting a 'functional cure' for HIV is more than just a pipe dream.

HIV virus
Abivax targets HIV in a new way

More from R&D

More from Scrip